• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney Invest Now master your money
Moneycontrol

Home » News » Business

Jan 13, 2017, 02.00 PM | Source: PTI

Cadila settles patent litigation related to anti-seizure drug

The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Upsher-Smith Laboratories, Inc to settle all outstanding patent litigation related to Qudexy XR, Cadila Healthcare said in a statement.

Like this story, share it with millions of investors on M3

Cadila settles patent litigation related to anti-seizure drug

The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Upsher-Smith Laboratories, Inc to settle all outstanding patent litigation related to Qudexy XR, Cadila Healthcare said in a statement.

Post Your Comments

Share Cancel

Cadila settles patent litigation related to anti-seizure drug
Drug firm Cadila Healthcare today said it has settled all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules with US-based Upsher-Smith Laboratories, Inc.

The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Upsher-Smith Laboratories, Inc to settle all outstanding patent litigation related to Qudexy XR, Cadila Healthcare said in a statement.

"Under the terms of the agreement, Upsher-Smith grants Zydus a licence to market Zydus' generic version of Qudexy XR beginning on March 19, 2020, or earlier under certain circumstances," it added.

Other terms of the settlement were not disclosed.

Qudexy XR extended-release capsules are used to treat certain kind of seizures in adults.

The Ahmedabad-based Zydus group employs over 19,500 people worldwide.

Shares of Cadila Healthcare were trading at Rs 351.40 apiece on the BSE, up 0.27 percent from previous close.

Buy, Hold, Sell ? Hear it first on M3
Cadila settles patent litigation related to anti-seizure drug

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login